anti-influenza immunoglobulin intravenous
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for anti-influenza immunoglobulin intravenous, covering 2020-10-05 to 2020-10-05. Get the full timeline:
Most recent: Clinical Trial Update: Exploring Safety & Clinical Benefit of Anti-Influenza Immunoglobulin Intravenous in Hospitalized Adults With Influenza A [Phase 2]